Price
Target price
€7.68
€7.68
13.120%
0.9
13.120%
€9.50
20.08.26 / Tradegate
WKN: A2DT49 / Symbol: IOVA / Name: Iovance Biotherapeutics / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Iovance Biotherapeutics Inc. Stock
A very strong showing by Iovance Biotherapeutics Inc. today, with an increase of €0.90 (13.120%) compared to yesterday's price.
Iovance Biotherapeutics Inc. is currently one of the favorites of our community with 8 Buy predictions and no Sell predictions.
As a result the target price of 9 € shows a slightly positive potential of 17.19% compared to the current price of 7.68 € for Iovance Biotherapeutics Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Iovance Biotherapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Iovance Biotherapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Iovance Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | 13.120% | 17.667% | 57.159% | 206.661% | 189.207% | 22.763% | -60.665% |
| Ionis Pharmaceuticals Inc. | -1.880% | 6.074% | 9.420% | 42.693% | -23.426% | 45.566% | 60.568% |
| United Therapeutics | 0.530% | 2.118% | -3.162% | 68.513% | 6.085% | 114.631% | 166.647% |
| Novocure Ltd | -2.440% | 1.895% | 11.516% | 50.483% | 37.539% | -45.774% | -85.872% |
Comments
Iovance Biotherapeutics (IOVA) had its price target raised by Mizuho from $10.00 to $11.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics (IOVA) had its price target lowered by Chardan Capital from $16.00 to $14.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics (IOVA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $16.00 price target on the stock.
Show more
Ratings data for IOVA provided by MarketBeat